Cannabis companies like Tilray Brands and Canopy Growth could soon face a more mellow path ahead following President Donald ...
President Donald Trump signed an executive order Thursday to reclassify marijuana as a Schedule III drug, a move aimed at ...
Marijuana’s classification as one of the most dangerous and habit-forming substances has long drawn criticism.
The New York State Office of Cannabis Management voted Thursday to reopen a shuttered upstate medical marijuana production ...
A Fulton County marijuana processor has filed a lawsuit challenging the constitutionality of New York's mandatory ...
New research reveals significant gaps between public perception and scientific evidence for medical cannabis benefits across ...
Trump signed an EO to reschedule cannabis, lifting 280E taxes for US MSOs like Cresco Labs, as shares fell on profit taking.
The move reclassifies marijuana as a less dangerous drug and open new avenues for medical research, a major shift in federal ...
It was the first time in nearly a year that hearings in the case had been convened, with a new judge presiding. Khalid Shaikh ...
A federally funded study published by the American Medical Association (AMA) is adding more evidence that marijuana can serve ...
The new law essentially overturns changes in federal agriculture law that went into effect in 2018. Those 2018 changes deregulated hemp products, and led to the proliferation of hemp cannabis that was ...
New regulations are set to change how dispensaries like The Good Life Collective on Monroe Avenue can advertise in New York.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results